Publications by authors named "Ana Vallejo-De-La-Cueva"
Background: Detecting pain in sedated critically ill patients requires utmost attention.
Aim: To assess the pain in mechanically ventilated critically ill patients with the Behavioral Pain Scale (BPS), Behavioral Indicators Pain Scale (ESCID), the pupillary dilation response (PDR), and vital signs.
Design: Cross-sectional study METHODS: The study was conducted between March and December 2019, involving patients with a baseline BPS of 3, ESCID of 0, and RASS between -1 and -4.
Background: More than 70% of patients demonstrate pain after endotracheal aspiration. Tools are needed to objectify the need for analgesia in non-communicative critically ill patients.
Objective: The objective of this study was to identify the lowest intensity electrical stimulus for detecting pain before daily care interventions.
Background: The objective of this study was to assess the value of the pupillary dilation reflex as an assessment pain tool in critically ill patients. It is important to continue working for the well-being and security of critically ill patients.
Methods: We studied the diagnostic accuracy of the pupillary dilation reflex against the Behavioral Pain Scale.
One of the most severe effects of coronavirus disease 2019 (COVID-19) is lung disorders such as acute respiratory distress syndrome. In the absence of effective treatments, it is necessary to search for new therapies and therapeutic targets. Platelets play a fundamental role in respiratory disorders resulting from viral infections, being the first line of defense against viruses and essential in maintaining lung function.
View Article and Find Full Text PDFArticle Synopsis
- * Conducted across 69 adult ICUs in 14 countries, the study analyzed data from 2088 patients aged 18 and older who were admitted with severe COVID-19 before April 28, 2020, excluding those with certain pre-existing conditions.
- * The findings revealed that out of 4530 admitted patients, 66.9% required invasive mechanical ventilation, highlighting the significant risk of acute brain dysfunction among severely ill COVID-19 patients.